Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

Pregnancy and ChildbirthReproductive Health

Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

Eur J Heart Fail.

Sliwa K, Petrie MC, Hilfiker-Kleiner D, Mebazaa A, Jackson A, Johnson MR, van der Meer P, Mbakwem A, Bauersachs J

doi: 10.1002/ejhf.1178.

Pregnancy and Childbirth

The challenge of cardiomyopathies and heart failure in pregnancy

Curr Opin Obstet Gynecol.

Limongelli G, Rubino M, Esposito A, Russo M, Pacileo G

doi: 10.1097/GCO.

Pregnancy and Childbirth

Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies

Circulation.

Boyd HA, Basit S, Behrens I, Leirgul E, Bundgaard H, Wohlfahrt J, Melbye M, Øyen N

doi: 10.1161/CIRCULATIONAHA.

Pregnancy and Childbirth

Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study

J Am Coll Cardiol.

Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, Wald RM, Colman JM, Siu SC

doi: 10.1016/j.jacc.2018.02.076.

Pregnancy and ChildbirthReproductive Health

What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF/ICSI?

Hum Reprod.

Koot YEM, Hviid Saxtorph M, Goddijn M, de Bever S, Eijkemans MJC, Wely MV, van der Veen F, Fauser BCJM, Macklon NS

doi: 10.1093/humrep/dez120.

Reproductive Health

Factors Associated with Postpartum Use of Long-Acting Reversible Contraception

Am J Obstet Gynecol.

Oduyebo T, Zapata LB, Boutot ME, Tepper NK, Curtis KM, D'Angelo DV, Marchbanks PA, Whiteman MK

doi: 10.1016/j.ajog.2019.03.005.

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

doi: 10.1186/s10194-017-0815-1.

Pregnancy and Childbirth

Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC)

Eur Heart J.

Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, Jondeau G, Budts W, Grewal J, Sliwa K, Parsonage W, Maggioni AP, van Hagen I, Vahanian A, Tavazzi L, Elkayam U, Boersma E, Hall R

doi: 10.1093/eurheartj/ehz136.

Further Publications Gynecology

Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study

Hum Reprod

Rossi G, Kicinski M, Suciu S, Vandecruys E, Plat G, Uyttebroeck A, Paillard C, Barbati M, Dresse MF, Simon P, Minckes O, Pluchart C, Ferster A, Freycon C, Millot F, van der Werff Ten Bosch J, Chantrain C, Paulus R, de Rojas T, de Schaetzen G, Rohrlich P, Benoit Y, Piette C

doi: 10.1093/humrep/deab236

Related content

Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

The challenge of cardiomyopathies and heart failure in pregnancy

Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies

Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study

What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF/ICSI?

Factors Associated with Postpartum Use of Long-Acting Reversible Contraception

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC)

Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study